Chetan T. Goudar

Amgen (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index2.2kcitations103works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infectious Diseases and Gene Expression in Insects(67), Protein purification and stability(26), Microbial Metabolic Engineering and Bioproduction(16), 3D Printing in Biomedical Research(10), Gene Regulatory Network Analysis(7)

Publications103 total

Automatic Assay Preparation Platform (A2P2) for Real‐Time Critical Quality Attributes Monitoring of Cell Culture Samples
Biotechnology Journal·2025Open Access
Biotechnology and Bioengineering: Volume 121, Number 4, April 2024
Biotechnology and Bioengineering·2024Open Access
Accelerating attribute‐focused process and product development through the development and deployment of autonomous process analytical technology platform system
Biotechnology and Bioengineering·2024· 6 cited
Accelerating Attribute-Focused Process and Product Development Through the Development and Deployment of Autonomous Process Analytical Technology Platform System
2023Open Access
Critical Aspects of pH Measurement for Bacteriostatic Water for Injection
Journal of Pharmaceutical Sciences·2023· 1 cited
Engineering protein glycosylation in CHO cells to be highly similar to murine host cells
Frontiers in Bioengineering and Biotechnology·2023· 12 citedOpen Access
Investigation of a failed <scp>DNA</scp> assay leads to identification of an unexpected contaminant in a commonly used chromatography buffer
Biotechnology Progress·2022
State-of-the-art and emerging trends in analytical approaches to pharmaceutical-product commercialization
Current Opinion in Biotechnology·2022· 6 cited
Author response for "Investigation of a failed DNA assay leads to identification of an unexpected contaminant in a commonly used chromatography buffer"
2022
A high-resolution multi-attribute method for product characterization, process characterization, and quality control of therapeutic proteins
Analytical Biochemistry·2022· 25 citedOpen Access
Enabling development, manufacturing, and regulatory approval of biotherapeutics through advances in mass spectrometry
Current Opinion in Biotechnology·2021· 22 cited
From chemostats to high‐density perfusion: the progression of continuous mammalian cell cultivation
Journal of Chemical Technology & Biotechnology·2021· 17 cited
Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles
Biotechnology Progress·2020· 39 cited
Methods for Estimating the Probability of Clonality in Cell Line Development
Biotechnology Journal·2019· 14 cited
Novel periodic alternating tangential filtration harvest approach provides incresed volumetric productivity
2019
Editorial overview: Latest Advances and Current Challenges in Biomanufacturing
Current Opinion in Chemical Engineering·2018
Upstream process intensification and continuous manufacturing
Current Opinion in Chemical Engineering·2018· 89 cited
Towards next generation CHO cell line development and engineering by systems approaches
Current Opinion in Chemical Engineering·2018· 55 cited
Characterization of phenotypic and genotypic diversity in subclones derived from a clonal cell line
Biotechnology Progress·2018· 47 citedOpen Access
Rethinking clonality using modeling approaches
2018
page 1 of 6Next →

Frequent Co-authors

James M. Piret(8), Hương Giang Lê(7), Jagadeesh R. Sonnad(6), Keith A. Strevett(5), Konstantin Konstantinov(4), Konstantin B. Konstantinov(4), Richard Biener(3), Tharmala Tharmalingam(3), Jennitte Stevens(3), Cary Matanguihan(2), Chun Chen(2), H. Edward Wong(2), Konstantinov B. Konstantinov(2), Maria I. Klapa(2), Chao‐Hsiang Wu(2), Chun Zhang(2), Kristi Daris(2), Trent P. Munro(2), Kim Le(2), Neil Soice(2)